Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

HTLV-II associated myelopathy in 43-year-old woman. REDS Investigators.

Murphy EL, Engstrom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG.

Lancet. 1993 Mar 20;341(8847):757-8. No abstract available.

PMID:
8095653
2.

HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.

Murphy EL, Fridey J, Smith JW, Engstrom J, Sacher RA, Miller K, Gibble J, Stevens J, Thomson R, Hansma D, Kaplan J, Khabbaz R, Nemo G.

Neurology. 1997 Feb;48(2):315-20.

PMID:
9040713
3.

HTLV-II and HTLV-I associated myelopathy.

[No authors listed]

Lancet. 1991 Oct 12;338(8772):944-5. No abstract available.

PMID:
1681285
4.

Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.

Miyamoto K, Nakamura T, Nagataki S, Tomita N, Kitajima K.

Jpn J Cancer Res. 1992 May;83(5):415-7.

PMID:
1618692
5.

Spastic ataxia associated with human T-cell lymphotropic virus type II infection.

Harrington WJ Jr, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SK, Snodgrass S, Toedter G, Cabral L, Poiesz B.

Ann Neurol. 1993 Apr;33(4):411-4.

PMID:
8489213
6.

HTLV-II in patients with HTLV-I-associated myelopathy.

Kira J, Koyanagi Y, Hamakado T, Itoyama Y, Yamamoto N, Goto I.

Lancet. 1991 Jul 6;338(8758):64-5. No abstract available.

PMID:
1676126
7.

A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II.

Biglione MM, Pizarro M, Salomón HE, Berría MI.

Clin Infect Dis. 2003 Aug 1;37(3):456-8. Epub 2003 Jul 17.

PMID:
12884173
8.

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ.

J Infect Dis. 1997 Dec;176(6):1468-75.

PMID:
9395356
9.

Tuberculous meningoencephalomyelitis and coinfection with HTLV-I + HTLV-II: case report.

Menna-Barreto M, Machado DC.

Arq Neuropsiquiatr. 2006 Mar;64(1):125-7. Epub 2006 Apr 5.

10.

HTLV-II infection associated with a chronic neurodegenerative disease: clinical and molecular analysis.

Silva EA, Otsuki K, Leite AC, Alamy AH, Sá-Carvalho D, Vicente AC.

J Med Virol. 2002 Feb;66(2):253-7.

PMID:
11782936
11.

Clinical and epidemiological aspects of HTLV-II infection in São Paulo, Brazil: presence of tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) simile diagnosis in HIV-1-co-infected subjects.

Posada-Vergara MP, Montanheiro P, Fukumori LM, Bonasser F, Duarte AJ, Penalva de Oliveira AC, Casseb J.

Rev Inst Med Trop Sao Paulo. 2006 Jul-Aug;48(4):207-10.

12.

Erectile insufficiency as first symptom of HTLV I/II associated myelopathy. Case report.

Oliveira JT, Carneiro-Proietti AB, Lima-Martins MV, Martins ML, Proietti FA.

Arq Neuropsiquiatr. 1998 Mar;56(1):123-5.

PMID:
9686133
13.

[Myelopathy in HIV and HTLV-2 coinfected patient].

Ramírez Montesinos R, Ruiz Ruiz S, López-Dupla M, Richart Jurado C.

Rev Clin Esp. 2010 Feb;210(2):94-6. doi: 10.1016/j.rce.2009.04.008. Spanish. No abstract available.

PMID:
20144812
14.

Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II.

Berger JR, Svenningsson A, Raffanti S, Resnick L.

Neurology. 1991 Jan;41(1):85-7.

PMID:
1985300
15.

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

Virol J. 2013 Dec 23;10:360. doi: 10.1186/1743-422X-10-360.

16.

HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.

de Araujo AC, Casseb JS, Neitzert E, de Souza ML, Mammano F, Del Mistro A, De Rossi A, Chieco-Bianchi L.

Eur J Epidemiol. 1994 Apr;10(2):165-71.

PMID:
7813694
17.

Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.

Murphy EL, Wang B, Sacher RA, Fridey J, Smith JW, Nass CC, Newman B, Ownby HE, Garratty G, Hutching ST, Schreiber GB.

Emerg Infect Dis. 2004 Jan;10(1):109-16.

18.

Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid.

Rosenblatt JD, Tomkins P, Rosenthal M, Kacena A, Chan G, Valderama R, Harrington W Jr, Saxton E, Diagne A, Zhao JQ, et al.

AIDS. 1992 Oct;6(10):1151-8.

PMID:
1466847
19.

Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.

Murphy EL, Glynn SA, Fridey J, Smith JW, Sacher RA, Nass CC, Ownby HE, Wright DJ, Nemo GJ.

Arch Intern Med. 1999 Jul 12;159(13):1485-91.

PMID:
10399901
20.

[Seropositivity of anti-HTLV-II antibodies in patients with HTLV-I-associated myelopathy and adult T-cell leukemia].

Nishimura Y, Yoshiki K, Yamaguchi K, Kiyokawa T, Takatsuki K.

Rinsho Byori. 1991 Dec;39(12):1351-2. Japanese.

PMID:
1779473

Supplemental Content

Support Center